• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于定量生物体液中p185HER2细胞外结构域的酶联免疫吸附测定。

ELISA for quantitation of the extracellular domain of p185HER2 in biological fluids.

作者信息

Sias P E, Kotts C E, Vetterlein D, Shepard M, Wong W L

机构信息

Department of Immunology Research and Assay Technologies, Genentech Inc., So. San Francisco, CA 94080.

出版信息

J Immunol Methods. 1990 Aug 28;132(1):73-80. doi: 10.1016/0022-1759(90)90400-p.

DOI:10.1016/0022-1759(90)90400-p
PMID:1975263
Abstract

The HER2/neu proto-oncogene encodes a receptor that belong to the tyrosine-specific protein kinase family. Amplification of the HER2 gene in patients with breast and ovarian cancer has been shown to predict poorer survival rates. In order to understand the role of HER2 in malignant and normal cells, it is necessary to devise assays that can quantitate expression levels of the HER2 gene product (p185HER2) in production samples, biopsy specimens and biological fluids. We have developed a simple, quantitative ELISA that uses two monoclonal antibodies directed against the extracellular domain of the HER2 gene product, p185HER2 (HER2 ECD). The assay has a detection range of 0.25-120 ng/ml, is precise and sensitive. The ability of this assay to detect biologically active rHER2 ECD is demonstrated by its correlation to a growth inhibitory bioassay (r = 0.92). The sandwich ELISA can also accurately quantitate rHER2 ECD in mouse and monkey serum. This assay should be useful for quantitating low levels of circulating rHER2 ECD in animals in which rHER2 ECD is being used as antigen for immunotherapy and in patients which 'shed' receptor.

摘要

HER2/neu原癌基因编码一种属于酪氨酸特异性蛋白激酶家族的受体。乳腺癌和卵巢癌患者中HER2基因的扩增已被证明预示着较差的生存率。为了了解HER2在恶性细胞和正常细胞中的作用,有必要设计出能够对生产样品、活检标本和生物体液中HER2基因产物(p185HER2)的表达水平进行定量的检测方法。我们开发了一种简单的定量酶联免疫吸附测定(ELISA),它使用两种针对HER2基因产物p185HER2(HER2胞外域)胞外域的单克隆抗体。该检测方法的检测范围为0.25 - 120 ng/ml,精确且灵敏。该检测方法检测生物活性重组人HER2胞外域(rHER2 ECD)的能力通过其与生长抑制生物测定的相关性得到证明(r = 0.92)。夹心ELISA还能准确地对小鼠和猴血清中的rHER2 ECD进行定量。该检测方法对于定量在将rHER2 ECD用作免疫治疗抗原的动物以及“脱落”受体的患者中循环的低水平rHER2 ECD应该是有用的。

相似文献

1
ELISA for quantitation of the extracellular domain of p185HER2 in biological fluids.用于定量生物体液中p185HER2细胞外结构域的酶联免疫吸附测定。
J Immunol Methods. 1990 Aug 28;132(1):73-80. doi: 10.1016/0022-1759(90)90400-p.
2
ELISA for quantitation of L-selectin shed from leukocytes in vivo.
J Immunol Methods. 1992 Nov 25;156(1):115-23. doi: 10.1016/0022-1759(92)90017-n.
3
Differential responses of human tumor cell lines to anti-p185HER2 monoclonal antibodies.人肿瘤细胞系对抗p185HER2单克隆抗体的不同反应。
Cancer Immunol Immunother. 1993 Sep;37(4):255-63. doi: 10.1007/BF01518520.
4
The unique monoclonal antibodies and immunochemical assay for comprehensive determination of the cell-bound and soluble HER2 in different biological samples.用于全面测定不同生物样本中细胞结合型和可溶性 HER2 的独特单克隆抗体和免疫化学检测方法。
Sci Rep. 2024 Feb 17;14(1):3978. doi: 10.1038/s41598-024-54590-z.
5
Fatty acid synthase activity regulates HER2 extracellular domain shedding into the circulation of HER2-positive metastatic breast cancer patients.脂肪酸合酶活性调节 HER2 阳性转移性乳腺癌患者循环中 HER2 细胞外结构域的脱落。
Int J Oncol. 2009 Dec;35(6):1369-76. doi: 10.3892/ijo_00000455.
6
ELISA assay employing epitope-specific monoclonal antibodies to quantify circulating HER2 with potential application in monitoring cancer patients undergoing therapy with trastuzumab.采用针对表位的单克隆抗体进行 ELISA 检测,定量检测循环中的 HER2,有望用于监测接受曲妥珠单抗治疗的癌症患者。
Sci Rep. 2020 Feb 20;10(1):3016. doi: 10.1038/s41598-020-59630-y.
7
Monoclonal antibody therapy of human cancer: taking the HER2 protooncogene to the clinic.人类癌症的单克隆抗体疗法:将HER2原癌基因应用于临床
J Clin Immunol. 1991 May;11(3):117-27. doi: 10.1007/BF00918679.
8
Utility of serum HER2 extracellular domain assessment in clinical decision making: pooled analysis of four trials of trastuzumab in metastatic breast cancer.血清HER2细胞外结构域评估在临床决策中的效用:曲妥珠单抗治疗转移性乳腺癌四项试验的汇总分析
J Clin Oncol. 2009 Apr 1;27(10):1685-93. doi: 10.1200/JCO.2008.16.8351. Epub 2009 Mar 2.
9
The extracellular domain of HER2/neu is a potential immunogen for active specific immunotherapy of breast cancer.
J Biol Response Mod. 1990 Oct;9(5):449-55.
10
[Changes in immune function of dendritic cells infected by recombinant adenovirus containing Her2/neu gene of extracellular and transmembrane domain proteins].[含细胞外和跨膜结构域蛋白Her2/neu基因的重组腺病毒感染的树突状细胞免疫功能变化]
Nan Fang Yi Ke Da Xue Xue Bao. 2006 Aug;26(8):1184-7.

引用本文的文献

1
Current status of the prognostic molecular biomarkers in breast cancer: A systematic review.乳腺癌预后分子生物标志物的现状:一项系统综述。
Oncol Lett. 2017 Mar;13(3):1491-1498. doi: 10.3892/ol.2017.5609. Epub 2017 Jan 17.
2
Soluble human epidermal growth factor receptor 2 (HER2) levels in patients with HER2-positive breast cancer receiving chemotherapy with or without trastuzumab: results from North Central Cancer Treatment Group adjuvant trial N9831.曲妥珠单抗辅助治疗 HER2 阳性乳腺癌患者的化疗联合或不联合曲妥珠单抗:来自美国西北肿瘤协作组 N9831 辅助试验的可溶性人表皮生长因子受体 2(HER2)水平结果。
Cancer. 2013 Aug 1;119(15):2675-82. doi: 10.1002/cncr.28130. Epub 2013 Jun 6.
3
Increasing the sensitivity of reverse phase protein arrays by antibody-mediated signal amplification.
通过抗体介导的信号放大提高反相蛋白质阵列的灵敏度。
Proteome Sci. 2010 Jun 22;8:36. doi: 10.1186/1477-5956-8-36.
4
Humanization of a recombinant monoclonal antibody to produce a therapeutic HER dimerization inhibitor, pertuzumab.一种重组单克隆抗体的人源化,以生产治疗性HER二聚化抑制剂帕妥珠单抗。
Cancer Immunol Immunother. 2006 Jun;55(6):717-27. doi: 10.1007/s00262-005-0058-x. Epub 2005 Sep 3.
5
Protein quantification from complex protein mixtures using a proteomics methodology with single-cell resolution.使用具有单细胞分辨率的蛋白质组学方法从复杂蛋白质混合物中进行蛋白质定量分析。
Proc Natl Acad Sci U S A. 2001 May 8;98(10):5497-502. doi: 10.1073/pnas.101124598. Epub 2001 Apr 24.
6
Differential responses of human tumor cell lines to anti-p185HER2 monoclonal antibodies.人肿瘤细胞系对抗p185HER2单克隆抗体的不同反应。
Cancer Immunol Immunother. 1993 Sep;37(4):255-63. doi: 10.1007/BF01518520.
7
Determination of a fragment of the c-erbB-2 translational product p185 in serum of breast cancer patients.乳腺癌患者血清中c-erbB-2翻译产物p185片段的测定。
J Cancer Res Clin Oncol. 1993;119(5):249-52. doi: 10.1007/BF01212719.